Purpose: To standardize in-vitro antifungal susceptibility testing by agar dilution method to find out the minimum inhibitory concentration (MIC) of amphotericin B, fluconazole and ketoconazole on ocular fungal isolates. Methods: A total of 180 ocular fungal isolates (130 filamentous fungi and 50 yeasts) were included. The antifungal drugs such as amphotericin B (0.0625-8 µg/mL), fluconazole (0.2-819.6 µg/mL) and ketoconazole (0.025-6.4 µg/mL) were incorporated in doubling dilutions in the yeast nitrogen base medium. The MIC was determined as the lowest concentration of the antifungal drug preventing growth of macroscopically visible colonies on drug containing plates when there was visible growth on the drug -free control plates. Results: All 50 ocular isolates of yeast were susceptible to amphotericin B, while two (4%) and five (10%) strains were resistant to fluconazole and ketoconazole respectively. Of the 130 filamentous fungi tested, six (4.6%) were resistant to amphotericin B, 49 (37.7%) and 10 (7.6%) were resistant to fluconazole and ketoconazole respectively. Percentile 50 (MIC 50) and Percentile 90 (MIC 90) for all the three antifungal agents were calculated. Aspergillus niger, Aspergillus terreus and Candida krusei were found to be resistant to fluconazole and ketoconazole.
Fungi are opportunistic in the eye, since they rarely infect combined with the increasing number of reports of resistance healthy, intact ocular tissues. An overwhelming number of to the available antifungal agents has propelled interest in fungal genera and species have been implicated as cause of clinically relevant methods for antifungal sensitivity testing. The ophthalmic mycoses and this number is steadily increasing. need for antifungal susceptibility testing increases beyond Fungal keratitis and endophthalmitis are the major ocular testing Candida species because resistance to antifungal drugs infections in developing countries. Mycotic keratitis have been demonstrated against such diverse fungi as apparently occurs much more frequently in India than in Cryptococcus neoformans, Aspergillus fumigatus, Aspergillus developed countries. 1 Fungi were identified as the principal terreus, Histoplasma capsulatum and Trichosporon species. aetiological agent of corneal ulceration (44%) in India. 2 Hence it becomes evident that the need for meaningful susceptibility test result is very important for fungi as it is for Fungal keratitis contributes to 6 to 56% 3 of keratitis and bacteria. 6 Although antifungal susceptibility testing remains less fungal endophthalmitis contributes to 4 to 11% of all cases of well-established and utilized than antibacterial testing, the endophthalmitis. 4 scientific support for its validity has benefited greatly by
The epidemiological pattern of corneal ulceration varies extrapolation from antibacterial testing. 7 The methods for significantly from country to country and even from region to region. Fusarium species (47.1%) and Aspergillus species (16.1%) are the most common aetiological agents of corneal ulceration in India 5 and natamycin (5%) or amphotericin B (0.15%) remain the drug of choice for superficial keratitis. 1 The recent explosion in the rates of opportunistic fungal infections, *Corresponding author (email: <lilyirudayam@gmail.com> 
Materials and Methods
The Tables 1 and 2 . The fungi were isolated by the standard procedures 12 from corneal scrapings of keratitis and endopthalmitis patients. The yeast were identified by the standard germ tube test and fermentation and assimilation of carbohydrate tests. The filamentous fungi were identified based on colony morphology and by lactophenol cotton blue mount preparation of the slide cultures. The fungal isolates of donor corneal rim (DCR) and conjunctival swab were not associated with any clinical disease. However, these were also included to determine the MICs of amphotericin B, ketoconazole and fluconazole on ocular fungal isolates.
Preparation of stock solutions of antifungal agents
. m e d k n o w . c o m
) .
standardization of in-vitro susceptibility testing, based on guidelines of CLSI 8 which states that ideal reference strains for quality control have MICs that fall near the mid-range of the concentration for all antifungal drugs.
Ocular isolates of fungi included in the study
Fifty ocular isolates of yeast and 130 filamentous fungi were included in the study. The distribution of the isolates of
We have followed the guidelines of CLSI 8 for preparing the various concentrations of antifungal drugs. The active components in amphotericin B obtained was 78% and ketoconazole and fluconazole were 70%.
The stock I solution of amphotericin B (HiMedia, India) was prepared by using 10 mg of amphotericin B dissolved in 1000 ml of dimethylsulfoxide (DMSO). 13 The working solution was prepared by 1 in 1000 dilution. The range of concentrations of amphotericin B was 0.0625-8 mg/mL; DMSO was used to dissolve amphotericin B following CLSI Candida parapsilosis guidelines. Fluconazole (Cipla Pharmaceuticals Limited, India) stock was 2 mg/mL. The aqueous stock solution was used directly without any further dilutions to obtain concentrations ranging from 0.2-102.4 µg/mL Ketoconazole (Cadila Pharmaceuticals, India) stock solution was prepared by dissolving 2 mg of ketoconazole in 1 mL of methanol according to manufacturer's instructions. Working solution was 1 in 100 dilution to obtain concentrations ranging from 0.025-12.8 µg/mL. When water was used to dissolve ketoconazole, it resulted in precipitation of the drug. Hence, methanol was used to dissolve ketoconazole and diluted 100 times from the stock solution. The intermediate solution was (25) swab (12) (6) N = 50 further diluted to the final strength in the test medium.
Medium
The medium yeast nitrogen base (Himedia, India) was dissolved in Phosphate buffer pH 7 and it was autoclaved at 110°C for 10 minutes.
14 The medium (10 mL) was dispensed in sterile screw capped (15 ml volume) glass bottles and the required concentrations of amphotericin B, fluconazole and ketoconazole (doubling dilutions) were incorporated in the medium. With each set a growth control without the antifungal agent and solvent control DMSO for amphotericin B and methanol control for ketoconazole were included.
Cryptococcus species. Throughout the study, 48 hour, 72 hour and 96 hour readings (delayed growth) were taken and there was no change in the MIC values taken at 48 or 72 or 96 hours.
Criteria for susceptibility / resistance
The criteria for susceptibility / resistance for amphotericin B, fluconazole and ketoconazole 15 for the antifungal drugs is given in Table 3 . Percentile 90 and Percentile 50 of amphotericin B, fluconazole and ketoconazole refers to MIC 90 and MIC 50 16 respectively and was calculated for all ocular isolates.
Results
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Preparation of standard inoculum
The fungal strains were freshly subcultured on to Sabouraud dextrose agar and incubated at 25 o C for three days. The yeast cells and spores were suspended in sterile distilled water and counted using Neubauer chamber to obtain 10 5 cells/ mL. Ten microlitre of standardized suspension was inoculated onto the control plates and the media incorporated with the antifungal agents. The inoculated plates were incubated at 25 o C for 48 hours. The readings were taken at the end of 48 hours and 72 hours.
Interpretation of results
The MIC was the lowest concentration of drug preventing growth of macroscopically visible colonies on drug-containing plates when there was visible growth on the drug-free control plates. The MIC readings were taken at the end of 48 hours of incubation, when growth appeared on the control plate. The time period was followed according to CLSI which recommends 48 hours for yeast and filamentous fungi and 72 hours for 
Standardization of in-vitro susceptibility testing by agar dilution method
The in-vitro susceptibility testing of amphotericin B, fluconazole and ketoconazole on fungi was standardized by agar dilution method with standard ATCC Candida species. The results of MICs of amphotericin B, fluconazole and ketoconazole on standard strains are given in Table 4 .
The standardized in-vitro antifungal susceptibility testing technique was applied to determine the MICs of amphotericin B, fluconazole and ketoconazole on 180 ocular fungal isolates.
Results of MIC of amphotericin B on ocular fungal isolates
All the 50 Candida species tested were susceptible to amphotericin B. Among the 130 filamentous fungi tested, 124 (95.38%) were susceptible to amphotericin B while six (4.61%) were resistant to amphotericin B ( Table 5 ).
The six resistant strains were Aspergillus flavus (1), Fusarium species (2), isolated from 3 corneal scrapings and Aspergillus terreus, Aspergillus niger, Penicillium species isolated from DCR (3). Among the yeasts, the MICs of amphotericin B were within the range of 0.0625-0.125 µg/mL in 42 (84%) while 91 (70%) filamentous fungi had a MIC range of 0.0625-0.25 µg /mL. The in-vitro susceptibility testing using amphotericin B on ocular isolates is shown in Fig. 1 . Percentile 90 and Percentile 50 of amphotericin B are represented in chart 1. fluconazole Yeasts  12  18  12  6  2  0  0  0  5 0  Filamentous fungi  8  20  63  24  9  2  2  2  130  Total  20  38  75  30  11  2  2  2 
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Results of MICs of fluconazole on ocular fungal isolates
Of the 50 yeasts tested, 48 (96%) were sensitive to fluconazole with MIC < 51.2 µg/mL, while 2 (4%) were resistant (MIC of fluconazole 102.4-819.2 µg/mL).The two resistant yeasts (Candida krusei) were isolated from DCR and corneal scraping. Among the 130 filamentous fungi tested, 81 (62.3%) were sensitive to fluconazole while 49 (37.7%) were resistant to fluconazole ( Table 6 ).
The resistant strains were isolated from corneal scraping (25), corneal button (12) and DCR (12). Among the yeasts, 24 Though the percentage of resistance to fluconazole reported is high, 17 in the present study 38% resistance to fluconazole was encountered.
Results of MICs of ketoconazole on ocular fungal isolates
Of the 50 yeasts tested 45 (90%) were sensitive to ketoconazole (MIC of ketoconazole < 0.8 µg/mL) while 5 (10%) were resistant to ketoconazole (MIC of ketoconazole > 0.8 µg/ mL). The resistant strains were isolated from two corneal scrapings (C. albicans 1, C. tropicalis 1) and three DCRs (C. krusei-2 and C. albicans-1). Among the 130 filamentous fungi tested, 120 (92.3%) were sensitive to ketoconazole while 10 YNB Control DMSO Control Amphotericin B 2 µg/ml strains (48%) had MIC of fluconazole within the range of 0.2 6.4 µg /mL while 39 (30%) filamentous fungi had a MIC range of 25.6 or 51.2 µg /mL. The in-vitro susceptibility testing using fluconazole on ocular isolates is shown in Fig. 2 . Percentile 90 and Percentile 50 of fluconazole have been calculated and (7.6%) were resistant ( within the range of 0.2-0.8 µg /ml while 71 (54.6%) filamentous filamentous fungi.
Among the yeasts tested C. krusei had a higher percentile value of ketoconazole. The distribution of 72 resistant strains of ocular fungal isolates to amphotericin B, ketoconazole and fluconazole are given in Table 8 .
Discussion
The present study was designed to develop a simple, cost -effective procedure of agar dilution method to determine the MICs of antifungal drugs. Six ATCC strains were included in the study for correlation of the results with agar dilution method standardized in this study with the published reports of other standard methods of susceptibility testing. In a study conducted by Makimura et al 13 Candida albicans 90028 and Candida parapsilosis ATCC 90018 have been used to evaluate the standard dilution method against the frozen plate method. In yet another study 18 involving proficiency testing, the other Candida species, Candida parapsilosis ATCC 22019, Candida tropicalis ATCC 750 and Candida krusei ATCC 6258 were used to evaluate the standard dilution method against the frozen plate method.
Makimura et al
13 used DMSO as solvent for preparation of the stock solution of amphotericin B, which was adopted in the present study. Methanol was used instead of distilled of compounds with low solubility in aqueous media and the drugs were from that of external ocular specimens and the same dilution of methanol was used without the drug for the percentage of resistance to amphotericin B, fluconazole and control plate to ensure that the particular concentration did ketoconazole were comparable to that of the published not inhibit the growth of the fungal strains.
reports. 1 Additionally, among filamentous fungi, A. niger followed by A. terreus exhibited higher percentage of Interestingly, we found that majority of the ocular fungal resistance to amphotericin B, fluconazole and ketoconazole isolates were susceptible to amphotericin B, followed by and among the yeasts, C. krusei exhibited higher resistance ketoconazole and fluconazole. The percentage of resistance to fluconazole and ketoconazole. Majority of the ocular fungal to fluconazole and ketoconazole in the present study is isolates included in the study were susceptible to amphotericin comparatively lower than reported by Davey et al 19 and B when compared to ketoconazole and fluconazole which were Yoshida et al. 9 The results of the MIC of the antifungal agents effective mainly against yeasts. However, MIC results by agar dilution method on standard ATCC strains of Candida obtained on ocular fungal isolates by in-vitro sensitivity species standardized in this study and the published reports testing are only meaningful when compared to the ocular of MIC by CLSI broth dilution method were comparable, tissue concentrations of the drugs obtained after oral, topical indicating the suitability of the agar dilution method. The CLSI and parenteral administration. It should reliably predict the inbroth micro dilution method (M-27a) is time consuming, vivo response to therapy in human infections. However, drug expensive and technically difficult to perform. On the other pharmacokinetics and drug interactions, factors related to the hand the agar dilution method has two important advantages host immune response and/or the status of the current over the CLSI method. The first is the visual reading based underlying disease, proper patient management system and on the intensity of growth showing the clear end point of factors related to the virulence of the infecting organism and inhibition. 20 The second is that susceptibility testing of large its interactions with both the host and therapeutic agents number of fungi is easier and economical as four strains can appear to have more value than the MIC as predictors of be tested with one set of agar plates in the agar dilution clinical outcome. method whereas each strain needs one set of tubes in the 1 (11.1) CLSI method. The emergence of antifungal drug resistance has made susceptibility testing important 21 though the applicability of in-vitro antifungal sensitivity testing may not directly correlate well with the clinical outcome. The filamentous fungi resistant to amphotericin B in this study were A. flavus, A. terreus and Fusarium species. These findings correlated with the study conducted by Arikan et al 17 in which resistance to fluconazole was observed in 37.7% and to ketoconazole in 8.7% of the filamentous fungi. The percentage of resistance of fluconazole and ketoconazole correlated with the report published earlier. 20 In the present study, Fusarium species showed the highest resistance to fluconazole followed by A. flavus and Penicillium spp. An important finding in the present study is that all the resistant strains to the three antifungal
Conclusion
The present study indicates that the agar dilution method can be adopted for in-vitro antifungal sensitivity testing, as it is a simple, reproducible, cost effective and easy to perform technique in a routine clinical microbiology laboratory. ) .
